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Abstract
Background: Among illicit drugs, the prevalence of amphetamine-type stimulant (ATS) use is second only to cannabis. Currently,
there are no approved pharmacotherapies for ATS problems, but some face-to-face psychotherapies are effective. Web-based
interventions have proven to be effective for some substance use problems, but none has specifically targeted ATS users.
Objective: The objective of the study was to evaluate the effectiveness of a Web-based intervention for ATS problems on a
free-to-access site compared with a waitlist control group.
Methods: We used a randomized controlled trial design. The primary outcome measure was self-reported ATS use in the past
three months assessed using the Alcohol, Smoking, Substance Involvement Screening Test (ASSIST). Other measures included
quality of life (EUROHIS score), psychological distress (K-10 score), days out of role, poly-drug use, general help-seeking
intentions, actual help-seeking, and “readiness to change”. The intervention consisted of three fully automated, self-guided
modules based on cognitive behavioral therapy and motivation enhancement. The analysis was an intention-to-treat analysis using
generalized estimating equation models, with a group by time interaction as the critical assessment.
Results: We randomized 160 people (intervention n=81, control n=79). At three months, 35/81 (43%) intervention and 45/79
(57%) control participants provided follow-up data. In the intervention group, 51/81 (63%) completed at least one module. The
only significant group by time interaction was for days out of role. The pre/post change effect sizes showed small changes (range
d=0.14 to 0.40) favoring the intervention group for poly-drug use, distress, actual help-seeking, and days out of role. In contrast,
the control group was favored by reductions in ATS use, improvements in quality of life, and increases in help-seeking intentions
(range d=0.09 to 0.16).
Conclusions: This Web-based intervention for ATS use produced few significant changes in outcome measures. There were
moderate, but nonsignificant reductions in poly-drug use, distress, days partially out of role, and increases in help-seeking.
However, high levels of participant attrition, plus low levels of engagement with the modules, preclude firm conclusions being
drawn on the efficacy of the intervention and emphasize the problems of engaging this group of clients in a fully automated
program.
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Trial Registration: Australian and New Zealand Clinical Trials Registry: ACTRN 12611000947909;
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000947909 (Archived by WebCite at
http://www.webcitation.org/6SHTxEnzP).
(JMIR Mental Health 2014;1(1):e1)   doi:10.2196/mental.3278
KEYWORDS
amphetamine related disorders; Internet; World Wide Web; randomized control trial; cognitive therapy; online; Web-based;
motivational enhancement; intervention
Introduction
Global Assessment of Amphetamine Type Stimulant
Global assessments of illicit drugs place the prevalence of
amphetamine type stimulant (ATS) use second only to cannabis,
with an estimated 0.6% of the adult population thought to have
used ATS in the last year [1]. In 2010, about 2.2% of Australian
adults used methamphetamine/amphetamines and 3.1% used
“ecstasy” in the last year, which are the main drugs encompassed
by ATS [2]. This use translates into ATS being listed as the
primary drug of abuse for more than 20% of those in treatment
in Asia, 12% in North America, and 9% in Europe [3]. Even
though the consumption of more potent types of ATS, such as
crystalline methamphetamine, and utilization of more rapidly
absorbed routes of administration (ie, smoking, injecting) have
a high potential for developing dependence [4], most users do
not reach diagnostic criteria. Therefore, interventions are needed
across the spectrum from harm reduction for irregular
“recreational” use through to treatment of stimulant use
disorders [5].
Although ATS use is widespread, there is currently a lack of
cost-effective scalable interventions that can be used to address
dependence and other harms from ATS use [6], and no
pharmacotherapy has yet been approved as a treatment of ATS
dependence [7]. Currently, the treatment of ATS disorders relies
on psychosocial interventions, with positive outcomes reported
for the intensive application of psychological interventions such
as contingency management, cognitive behavior therapy (CBT)
and motivational interviewing (MI) [8]. Behavioral interventions
can be extremely resource intensive; with some interventions
requiring 156 weeks of treatment [8], so there have been
attempts to develop shorter programs. Brief CBT based
interventions, requiring up to four sessions, have resulted in
significant reductions in amphetamine use and greater likelihood
of abstinence than in control participants who just received a
self-help booklet [9]. In Australia, it is estimated that 33% of
dependent ATS users receive treatment for their ATS use in
any year [10], and the high prevalence of lifetime comorbidity
means that ATS users access health services more than those
with other substance use disorders or other mental health
disorders [11]. Nevertheless, traditional behavioral treatment
options are not generally accessed by ATS users, who frequently
report their needs are not being met in these settings [5].
Evidence Base for eHealth Interventions
In the light of evidence that psychological interventions can
reduce the use of ATS [8,9,12], there is potential to develop
Web-delivered, mobile telephone or computer-based (henceforth
referred to generically as “eHealth”) treatments for ATS users,
an approach that has been effective with other conditions. The
evidence base for the effectiveness of eHealth interventions for
illicit drug use is limited, and we are not aware of any eHealth
treatment interventions that currently exist specifically for ATS
users. A review of interventions for cannabis use found only
10 studies that reported outcomes on cannabis consumption
with an overall effect size of g=0.16 [13]. A review of eHealth
interventions for drug use more broadly identified programs
developed for specific drugs (eg, opiates) or interventions
covering a range of illicit drugs including amphetamine,
cannabis, cocaine, hallucinogens, inhalants, and opiates [14].
However, this review did not synthesize an overall outcome for
their effectiveness, but concluded that there was evidence for
their initial efficacy compared with control conditions [14].
Although not specifically ATS, one intervention has been
evaluated among consumers of cocaine [15]. Having recruited
196 participants, the percentage who completed follow-up at 4,
6, and 26 weeks was 17%, 15%, and 6%, illustrating the
difficulty of retaining this population in fully automated
interventions [15]. Unsurprisingly, given the small sample
retained (n=11 at 26 weeks) in the eHealth study, there were no
significant time by group interactions on the key outcome
measures, severity of dependence and craving [15]. Web-based
or computer-based interventions can also be delivered as an
adjunct to in-person treatment, which may serve to improve
retention. Data from a mixed cohort of substance dependent
individuals that received computer delivered (eg, at a clinic)
CBT in addition to in-person treatment retained 72% at three
months and 65% of participants at six months [16]. By
comparison, a review of in-person interventions reported
retention at three months ranging from 37% to 90% [6].
The aim of the current study was to evaluate a fully automated,
self-guided Web-delivered intervention, derived from
established psychological approaches (ie, CBT, MI), to reduce




We used a two-group randomized controlled trial, with the
intervention group receiving a Web-delivered intervention
comprised of three modules, which are described below. The
wait-list control group received the same assessment procedures
as the intervention group, but they were only able to access the
intervention resources after six months. We also provided all
participants with contact details for emergency services, such
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as Lifeline Australia. The full methodology has been described
previously in detail [17].
Sample
We recruited participants by advertising on social networking
sites and posters in local clinics. To be eligible, participants had
to be a resident of Australia, age 18 years or older, and to report
use of ATS (eg, meth/amphetamine, ecstasy, nonmedical use
of prescription stimulants) in the last three months. Given the
nature of the intervention, participants required access to the
Internet and a valid email address. We excluded those who were
currently receiving any treatment for stimulant
abuse/dependence or pharmacotherapy such as methadone,
naltrexone, or buprenorphine for a substance use disorder
(nicotine replacement therapy was permitted), or who reported
a lifetime diagnosis of schizophrenia, schizoaffective, or bipolar
disorder. In addition, nine cases were excluded as duplicate
registrations (eg, duplicate Internet protocol addresses/email
addresses/payment addresses. Inspection of log files by AB also
indicated that these were likely to be repeated registrations).
Figure 1 shows the flow of participants through the study.
Recruitment opened in January 2013 and closed in July 2013.
Of the 446 people assessed, 160 of 446 (35.8%) fulfilled the
study criteria.
Figure 1. CONSORT flow diagram.
Procedure
All stages of enrollment and screening were performed via the
free study website. Eligible participants provided active consent
by “clicking” on a box for each element of the consent form
(see Multimedia Appendix 1). A personalized link to access the
study was sent to verify their email address and to allow them
to create a username and password. Participants were directed
to a Web baseline survey before being randomized. We used a
simple randomization process that was fully automated with
permuted blocks of four with a one to one allocation ratio.
Participants who were not eligible for the study were provided
with information about other potentially useful websites and
resources.
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Those in the intervention group were given immediate access
to the first module. Participants were advised to allow one week
between modules, but could progress at their own pace, although
each page in a module had to be opened in sequence to complete
the module and obtain access to the next one. Reminder emails
were sent three days after the scheduled start date if it had not
been commenced, and at day seven when the next module was
due. This was repeated for the third module. An email invitation
to complete the follow-up assessment was sent after three
months. Participants received AU$20 for baseline and follow-up
assessments. The study received approval from The Australian
National University Human Research Ethics committee and
was registered with the Australian and New Zealand Clinical
Trials Registry ACTRN 12611000947909.
Modules
In developing the intervention, we drew on motivational
interviewing and CBT methods that had been used in clinical
practice with amphetamine users [18]. The approach was one
of harm minimization, with participants able to decide on the
most appropriate goals for themselves, for example, quitting
completely, reducing their drug use, and using in a less
hazardous manner. Module one explores the typical problems
which ATS users incur, including: (1) relationships with family
and friends, (2) health, (3) finances, (4) work/study, (5) legal
issues, (6) mental health, and (7) specific drug use problems.
The last page provides a summary of the endorsed problems,
and guides the participant to generate a “map” of the
interconnections between these issues. The second module
requires participants to think about the pros and cons of their
stimulant use, and the likely good and bad things related to
changing their behavior, and draws on the Miller and Rollnick
model [19]. To aid in their “decision balance” for each element
that they select, participants rate its importance. The last module
focuses on behavioral change, including techniques such as: (1)
setting clearly specified goals, (2) actions on specific dates, (3)
strategies to help with controlling and overcoming cravings, (4)
refusal skills, (5) managing a “slip”, and (6) an action plan to
deal with high risk situations. Sample images from the
intervention are available elsewhere [17] and in Multimedia
Appendices 2-5.
Measures
All the study measures were self-report. The primary outcome
measure was ATS use evaluated with the Alcohol, Smoking,
Substance Involvement Screening Test (ASSIST) [20]. The
ASSIST assesses lifetime and last three month use of nine drug
categories (ie, tobacco, alcohol, cannabis, cocaine, ATS,
inhalants, sedatives, hallucinogens, opioids, other). Data include
frequency of use, cravings, problems (health, social, legal, or
financial), failure to fulfill roles, concern expressed about their
drug use, and if the person has ever tried and failed to control
their drug use. Finally, injection of drugs was assessed. The
standard ASSIST scoring algorithm was used to calculate a
score for ATS use (range 0-39) [20].
We assessed secondary outcomes in terms of: (1) help-seeking
intentions (general help-seeking questionnaire, GHSQ) [21];
(2) actual help-seeking questionnaire (AHSQ) [22,23]; (3)
readiness to change, modified to assess ATS rather than alcohol
(Readiness to Change Questionnaire, RTCQ) [24]; (4)
psychological distress (Kessler-10 questionnaire, K-10) [25];
(5) poly-drug use measured by the ASSIST [20]; (6) days out
of role [26]; and (7) quality of life (European Health Interview
Survey, EUROHIS, Quality of Life scale) [27]. We also
collected demographic information (eg, age, sex, marital status),
drug use history (eg, age of first use of ATS), and severity of
dependence (Severity of Dependence Scale, SDS) [28].
The RTCQ has four items relating to each of the stages,
“precontemplation”; “contemplation”; and “action”. The five
point scales were summed to obtain scores for each stage, with
participants designated to their highest scoring stage, or in the
event of tied scores, the higher stage [24]. Psychological distress
was indexed as the total score (range 10-50) on the K-10 [25].
Poly-drug use was the sum of ASSIST classes of drugs endorsed,
excluding ATS use [20]. The GHSQ asked, “How likely is it
that you would seek help from each of the following people for
any amphetamine or other drug use problems during the next
4 weeks?”, and provided a list of nine potential sources of help
(eg, friend, mental health professional, other). The seven point
scale ranged from extremely unlikely (1) to extremely likely
(7). The AHSQ asked, “Which of the following people have
you gone to for advice or help in the past 2 weeks for any
amphetamine or other drug use problems?”, and listed the same
nine sources as the GHSQ. “Days out of role” was based on
Kessler’s questions, but referencing “ATS drug use (eg,
methamphetamine, ecstasy, ice)” rather than “depression” [26],
and quality of life was the total EUROHIS score [27].
Sample Size
The study was designed to detect a medium effect (eg, d=0.5)
[29] with power of 0.8, which requires a sample of 60 people
per group; to allow for 20% attrition, we recruited 80 people
per group. In estimating the sample size, we drew on findings
for stimulant users who were recruited in primary care settings
and received a brief intervention in the ASSIST development
study [20]. That group may be less heterogeneous than the
current sample.
Analysis
The primary analysis was an intention-to-treat (ITT) analysis
and used generalized estimating equation (GEE) models. This
approach overcomes many of the limitations of standard
repeated measures analysis of variance. It uses all available data
without requiring substitution or estimation of missing
independent variables to avoid the exclusion of cases with
noncomplete data and does not assume homogeneity of
correlations over waves of measurement [30,31]. For continuous
data, an unstructured correlation matrix was used together with
a normal distribution and identity link. Categorical outcome
measures were evaluated using GEE models with a multinomial
distribution and cumulative logit link. After inspection of the
data, days out of role, intended help-seeking, and number of
people actually sought help from, were assessed using a Poisson
distribution with a log link due to the positively skewed
distribution. Outcomes were tested as the group (intervention,
control) by time (baseline, three months) interaction. Due to
significant differences in baseline data (see Table 1), actual
help-seeking was included as a covariate, along with SDS, due
JMIR Mental Health 2014 | vol. 1 | iss. 1 | e1 | p.4http://www.jmir.org/2014/1/e1/
(page number not for citation purposes)
Tait et alJMIR MENTAL HEALTH
XSL•FO
RenderX
to its importance in predicting attrition (see “Follow-Up”
section). The primary outcome measure was the ASSIST ATS
score, with other measures deemed as secondary outcomes.
A sensitivity analysis was conducted using multiple imputation
of missing data using fully conditional specification with an
iterative Markov chain Monte Carlo method. Maximum and
minimum values were logically constrained, for example, to
the possible range of scores on questionnaires. Baseline
outcomes, plus demographic variables were used as predictors;
three month outcomes were dependent and predictor variables
in generating the 25 datasets. Effect sizes were calculated as
the difference in pretest posttest means for the two conditions,
divided by their common pretest standard deviation, multiplied
by a bias correction factor (1-(3/4(N treatment+ N control-2)-1),
Monte Carlo modeling shows that this provides the best estimate
of the population effect from the commonly used effect size
measures [32]. In addition, attrition was modeled with logistic
regression to investigate the characteristics of those lost to
follow-up. Baseline predictors were study group, RTC group,
age, age of first ATS use, gender, SDS, K-10, ASSIST ATS,
poly-drug use scores, actual help-seeking scores, and intended
help-seeking scores. Finally a “per protocol” analysis was
conducted to evaluate the effect of completing at least one
module of the intervention. The ITT and imputed analyses were
conducted blind to study condition by RJT.
Results
Group Characteristics
The characteristics of the two groups and overall sample at
baseline are shown in Table 1. On all measures, the two groups
reported similar baseline scores, except actual help-seeking,
where the control had significantly higher levels. There were
(38/60) 23.8% of the participants that were female; the mean
age was 22.4 (SD 6.3). About 1/3 of users only consumed ATS
occasionally (1-2 times in the last three months), with (62/160)
38.8% using ATS weekly or more frequently. Based on a SDS
threshold score of five or more, (57/160) 35.6% participants
were classified as “dependent”. The large majority had never
injected drugs (137/160, 85.6%).
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Table 1. Baseline characteristics by study group and sample.
StatisticTotal
N=160, n (%) or mean
(SD)
Intervention
n=81, n (%) or mean
(SD)
Control




χ21=1.80; P=.4138 (24)a17 (21)21 (27)aFemale
t158=0.34; P=.7422.4 (6.3)22.2 (5.5)22.5 (7.1)Age
Education
χ23=3.57; P=.318 (5)6 (8)2 (3)Primary
100 (65)50 (63)50 (67)Secondary
22 (14)9 (11)13 (17)Trade/technical
25 (16)15 (19)10 (13)University
Employment
χ23=0.60; P=.9028 (18)15 (19)13 (17)Full-time
31 (20)14 (18)17 (22)Part-time
33 (21)16 (21)17 (22)Unemployed
39 (41)33 (42)30 (39)Student
Amphetamine Type Stimulants (ATS) frequency last 3 months
χ23=6.41; P=.0947 (29)20 (25)27 (34)1-2
51 (32)33 (41)18 (23)Monthly
44 (28)21 (26)23 (29)Weekly
18 (11)7 (9)11 (14)Daily/almost daily
t158=0.08; P=.9318.1 (3.5)17.7 (2.6)18.6 (4.2)Age 1st ATS use
t158=1.72; P=.0916.9 (10.6)17.0 (10.1)16.8 (11.1)ATS score
t158=0.95; P=.344.7 (1.7)4.8 (1.8)4.6 (1.6)Poly-drug use
t158=0.40; P=.6920.1 (11.0)19.7 (11.2)20.4 (10.9)Intended help-seeking
t113=2.83 
b; P=.010.6 (1.1)0.3 (0.7)0.8 (1.3)Actual help-seeking
t158=0.02; P=.9822.2 (8.3)22.2 (8.4)22.3 (8.3)Kessler-10 (K-10) score
Injected any drug
χ22=0.58; P=.75137 (86)68 (84)69 (87)Never
8 (5)4 (5)4 (5)Yes, not last 3 months
15 (9)9 (11)6 (8)Yes, last 3 months
t158=0.63; P=.533.2 (5.7)3.5 (5.6)2.9 (5.9)Days out of role
t158=0.79; P=.433.6 (5.3)3.9 (5.3)3.2 (4.8)Days part out of role
t158=0.99; P=.3227.7 (6.1)27.2 (6.3)28.2 (5.8)Quality of life
Readiness to Change Questionnaire (RTCQ)
χ22=2.83; P=.2459 (37)27 (33)32 (41)Precontemplation
59 (37)35 (43)24 (30)Contemplation
42 (26)19 (24)23 (29)Action
t158=0.17; P=.863.7 (3.4)3.7 (3.5)3.8 (3.3)Severity of Dependence (SDS)
χ21=2.57; P=.1157 (36)24 (30)33 (42)SDS >5
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aOne person reported sex as “other”
bLevene’s correction for inequality of variances
bMissing data, education n=5, employment n=5
Engagement
From the 81 intervention participants, 51/81 (63%) completed,
13/81 (16%) started, and 17/81 (21%) did not attempt the first
module. The second module was completed by 45/81 (56%)
participants and started by another 2/81 (2%); the respective
figures for the third module were 39/81 (48%) and 4/81 (5%).
Thus, 39/81 (48%) completed all the modules, 6/81 (7%)
completed two modules, and six completed one module.
Follow-Up
At three months, 45/79 (57%) participants from the control and
35/81 (43%) from the intervention completed follow-up surveys
(Figure 1) (χ21=3.03 P=.08). The proportion who submitted
follow-up data in the intervention group varied with the number
of modules completed, 7 (23%) who completed no modules, 2
(33%) who completed one module, 4 (67%) who completed
two modules, and 22 (56%) who completed all three, Fisher’s
exact test 9.21, P=.02. Logistic regression showed that “loss to
follow-up” was not significantly related to group allocation.
However, higher depression scores increased the odds of
completing follow-up (odds ratio, OR) 1.06, 95% CI 1.00-1.11),
while the odds were reduced with higher baseline poly-drug use
OR 0.75 (95% CI 0.60-0.93), or higher baseline SDS OR 0.82
(95% CI 0.67-0.99).
Intention-to-Treat Analyses
The results of the ITT analyses showed that there was only one
significant group by time interaction for the outcome measures
(Table 2). Those in the intervention group had a reduction in
days out of role relative to the control group (estimated marginal
mean, EMM, baseline 3.3, standard error, SE, 1.6; three months
0.70, SE 0.43; vs control EMM 3.1, SE 1.6; 2.9, SE 2.0). Table
2 also shows the scores on the outcome measures at three months
together with the effect sizes. To facilitate the interpretation of
the effect sizes, the group favored by the change is noted in the
Table, because “improvements” constitute increases on some
measures (eg, EUROHIS) and decreases on others (eg, ATS
use). The majority of effect sizes favored the intervention group.
We observed that actual help-seeking was lower for the
intervention group at both time points, but their mean level
increased while the mean decreased for the controls. With
respect to RTC category, the proportion in the
“precontemplation” stage fell in the intervention group (27/81,
33% to 8/34, 24%) and remained stable in the control group
(32/79, 41% to 19/45, 42%). Changes in the proportions in the
“action” and “contemplation” stages were similar for the two
groups. The results for the pooled data after multiple imputations
showed similar outcomes to the main analyses with only one
significant group by time interaction. The intervention group
showed improved outcomes relative to the control group for
actual help-seeking (P=.02; intervention EMM baseline 0.32,
SE.09; three months 0.84, SE 0.22; vs control EMM 0.74, SE
0.20; 0.87, SE 0.23.
Table 2. OR for group by time interaction plus posttest outcomes and pre/posttest effect sizes. Group by time interaction is adjusted for the SDS score





(SD) or n (%)
Control
n=45, mean (SD) or
n (%)
OR (95% CI) group * time, mean
(SD) or n (%)
Variable
Control.84-0.1615.3 (9.3)13.5 (10.0)0.70 (0.02, 24.64)ATS score
Intervention.080.404.2 (1.8)4.6 (1.7)0.51 (0.24, 1.09)Poly-drug use
Control.460.0918.1 (7.3)19.5 (9.1)0.91 (0.72, 1.16)Intended help-seek
Intervention.14-0.330.57 (.92)0.69 (.95)1.90 (0.82, 4.39)Actual help-seek
Intervention.150.1520.3 (7.4)21.6 (7.7)0.15 (0.01, 1.97)K-10 score
Intervention.010.291.1 (2.1)2.2 (5.1)0.22 (0.07, 0.68)Days out of role
Intervention.150.142.9 (6.1)3.0 (5.5)0.45 (0.15, 1.33)Days part out of role
Control.470.1128.2 (5.0)29.8 (5.4)1.99 (0.31, 12.82)Quality of life
RTCQ




The final analysis compared those who completed one or more
modules (n=28), zero modules (n=7), or who were in the control
group (n=45). Of the outcome measures, only actual
help-seeking showed a significant interaction effect (OR 2.90,
95% CI 1.10-7.62). Actual help-seeking increased in those who
undertook at least one module (baseline mean 0.22, SE 0.08;
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three months 0.59, SE 0.21), whereas for both the control group
(baseline 0.72, SE 0.22; three months 0.67, SE 0.25) and the
zero module group (baseline 0.42, SE 0.15; three months 0.14,
SE 0.15) actual help-seeking decreased. Note, analysis of “per
protocol” data does not represent randomized outcomes.
Discussion
Principal Results
To the best of our knowledge, this is the first Web-based
intervention developed specifically for users of ATS. There was
only one (time by group) significant change on any of the key
outcome measures, with an improvement in the number of days
out of role for the intervention group. Further, the effect sizes
for the intervention were smaller than those estimated in the
design phase. The findings of the multiple imputations analysis
reinforce the conclusion that the study was “insufficiently
powered” to detect small effects. Nevertheless, to put these
outcomes into perspective, the effects were larger than those
recently reported for eHealth interventions for cannabis use [13]
and similar to those for brief face-to-face interventions for
alcohol use problems [33]. Thus, there is the potential that this
intervention could be of benefit to users of ATS, at least among
those with similar characteristics to this cohort. Nevertheless,
the high level of attrition and low level of engagement limit the
conclusions that can be drawn from these data. Improving
engagement is a critical goal for interventions with substance
using groups.
Moving beyond the ITT analysis, the effect size analysis and
the per-protocol analysis (eg, those completing one or more
modules) suggest that the intervention increases actual
help-seeking behavior in participants. A recent review has found
that it is difficult to change help-seeking, even where this is a
specific aim of the intervention, at least among samples with
common mental health disorders (eg, depression, anxiety) [34].
Brief interventions can result in small increases in help-seeking
in those with alcohol use problems, but are more effective in
those without comorbid mental health disorders [35]. This
reinforces the above review, which found effect sizes ranging
from d =−.02 to .24 for changing help-seeking [34]. Therefore,
the significant effects found in the per-protocol and multiple
imputed data analyses of the current study are an important
outcome for a low intensity intervention. Further research is
required to evaluate if this type of Web-based intervention can
be effectively integrated into a stepped-care program for ATS
users as previously recommended [5].
Given that the intervention specifically targeted and was
designed for users of ATS, it is surprising that the control group
had a greater decline in ATS use than the intervention group,
especially as the latter showed a greater reduction than the
control in poly-drug use, as indexed by the number of different
categories of drugs used in the last three months (excluding
ATS). The mean number of drug types used by participants was
four to five in addition to ATS. That the participants appear to
be opting to change other drug use, as shown by reduced
poly-drug scores, rather than their ATS use is of concern, as
even low frequency of exposure (ie, greater than five) to ATS
is associated with the development of stimulant use disorders
[11].
Limitations
There are a number of limitations that need to be acknowledged
in the interpretation of these findings. The sample would be
regarded as having less severe substance use problems, with
the large majority having never injected any drug and their
severity of dependence scores being low compared with ATS
treatment seeking groups (eg, 75% injecting ATS, mean severity
of dependence score approximately 9.0) [36]. Thus, care should
be taken in extrapolating beyond this type of ATS user.
Nevertheless, 57 participants scored five or more on the SDS
and, on the basis of this screening measure, are likely to be ATS
dependent [37]. The loss to follow-up of a significant proportion
of participants threatens the internal validity of the study.
Although this was not related to group allocation in a logistic
model, the association with increased severity of dependence
and poly-drug use reinforces the caveat that this type of low
intensity intervention may not be suitable for those with more
severe drug use problems, consistent with the broader literature
on brief interventions for substance use [33,38]. Indeed, the
small effect sizes reported for eHealth interventions with
cannabis users [13] could imply that more intensive
interventions are required for most illicit drug users. Other
eHealth interventions with illicit drug users (cocaine) have
encountered more extensive attrition [15], but the results
obtained in the current study are comparable with in-person
interventions for ATS [6] and consistent with the broader
literature from fully automated Internet interventions [39].
Differences between the groups in the proportion followed-up
may also threaten the internal validity.
A further concern is the low level of engagement with the
intervention (30/81) 37% of participants randomized to the
intervention did not complete the first module, and future
research is required to investigate ways to encourage
intervention completion. Although in a radically different sample
(adolescent girls), recruiting mother-daughter dyads has
achieved remarkable retention rates [13]; recruiting
“user-significant other” dyads might improve retention in other
drug use groups. This is particularly important given previous
findings that completion of at least one in-person module of a
four-session intervention for ATS was associated with greater
ATS reductions than those who did not return for any sessions
[9], in addition to our finding here that actual help-seeking
increased for people completing at least one module of the
Internet intervention. Similar findings have also been reported
for Internet support interventions where completion of a greater
number of modules following residential treatment was
associated with better posttreatment outcomes [40]. Finally, the
low level of engagement diminishes any potential difference
between the study groups.
Conclusions
The impact of eHealth treatment interventions for ATS drug
use remains open to question due to the small effects associated
with their application and their potential clinical relevance.
However, the impact of an intervention relates both to the
prevalence of the condition and its consequences. Thus, brief
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interventions by primary care physicians have a net benefit of
only 1%-3% in the cessation of smoking, but are still cost
effective and recommended [41,42]. The potential of eHealth
interventions to reach those unable or unwilling to access
conventional facilities means that they should be further
evaluated in large scale trials, including effectiveness trials to
determine if people will use them without research incentives.
It also seems warranted to evaluate their effect as an adjunct to
conventional treatment. Ways to further increase engagement
with Internet-based treatment programs require research
attention, particularly given the current debate as to whether or
not “supported” or “guided” eHealth interventions (ie, involving
some input from a therapist) are more effective than unguided
programs [43,44]. Including an easy means of providing
feedback at the end of each module could elicit data to modify
the intervention and, hence, improve the experience for users.
Without dramatic improvements in retention, substantially larger
studies will be required to detect small differences between
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